The company reported quarterly financial results, which have implications for shareholders.
*Stock prices used were the afternoon prices of Aug. 8, 2025. The video was published on Aug. 10, 2025.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Novo Nordisk Stock: Buy or Sell?
By Parkev Tatevosian, CFA
–
Aug 12, 2025 at 5:00AM
NYSE: NVO
Novo Nordisk
Market Cap
$168B
Today's Change
(-2.48%) -$1.26
Current Price
$49.81
Price as of August 11, 2025, 3:58 p.m. ET
News from a competitor is increasing enthusiasm for Novo Nordisk stock.
About the Author
A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
Stocks Mentioned
Novo Nordisk
NVO
$49.81
(-2.48%)
$-1.26
Eli Lilly
LLY
$634.94
(1.49%)
$9.29
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
4 of the Most Undervalued Stocks in the Market Right Now
2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold at Least a Decade
Why Novo Nordisk Stock Flew Higher on Friday
Novo Nordisk Stock Investors Need to Know This
Novo Nordisk Is Down 70%: Is the Price Too Low To Ignore?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.